Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease

The molecular scalpel of clustered regularly interspersed short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) technology may be sharp enough to begin cutting the genes implicated in inflammatory bowel disease (IBD) and consequently decrease the 6.3 billion dollar annual financial hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Limanskiy, Viktor, Vyas, Arpita, Chaturvedi, Lakshmi Shankar, Vyas, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526155/
https://www.ncbi.nlm.nih.gov/pubmed/31143069
http://dx.doi.org/10.3748/wjg.v25.i18.2177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526155/
https://www.ncbi.nlm.nih.gov/pubmed/31143069
http://dx.doi.org/10.3748/wjg.v25.i18.2177

Ejemplares similares